Equities research analysts at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a report released on Wednesday. The brokerage set a “hold” rating on the ...

CytoSorbents (CTSO) (ISIN: US23283X2062)股票专题，提供今日CytoSorbents(CTSO) (ISIN: US23283X2062)股票最新股价查询，实时市场行情，走势图表，及CytoSorbents Corp.(CTSO) (ISIN: US23283X2062)股票的专业技术分析，投资者论坛，历史交易数据，最新消息和未来价格预测。

Check a company’s competitiveness in the job market with alternative data that tracks hiring, job openings, and more.

Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.

13, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood ...

Analysts' ratings for CytoSorbents CTSO over the last quarter vary from bullish to bearish, as provided by 7 analysts. The table below offers a condensed view of their recent ratings, showcasing ...

PRINCETON, N.J., Jan. 13, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...

PRINCETON - CytoSorbents Corporation (NASDAQ:CTSO), a company specializing in blood purification therapies with a market capitalization of $51.21 million, today announced the establishment of a new ...